Determining the minimum inhibitory concentrations of pyrazinamide against <i>Mycobacterium tuberculosis</i> clinical isolates at a neutral pH of 6.8 using the broth microdilution method. [PDF]
Tamblin M, Shi W, Chen L, Reynolds J.
europepmc +1 more source
Exploring transmission dynamics in epidemiologically linked pulmonary tuberculosis cases and household contacts: a WGS-based investigation. [PDF]
Seid G +12 more
europepmc +1 more source
The epidemiology and gene mutation characteristics of pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates in Southern China. [PDF]
Wang N +17 more
europepmc +1 more source
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020. [PDF]
Tamilzhalagan S +16 more
europepmc +1 more source
Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities. [PDF]
Jung S.
europepmc +1 more source
Identification of Enzymatic Catalysis of PncA using 1H-NMR
Jong-Jae Yi +5 more
openaire +2 more sources
Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network
Dissanayake D, Morrone JA, Fowler PW.
europepmc +1 more source
Series 2: Development of a Multiplex Amplicon Next Generation Sequencing Assay for Rapid Assessment of Resistance-Associated Mutations in <i>M. tuberculosis</i> Clinical Cases. [PDF]
Cabrera A +14 more
europepmc +1 more source
Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of in KwaZulu-Natal, South Africa [PDF]
core +1 more source
A simplified pyrazinamidase test for <i>Mycobacterium tuberculosis</i> pyrazinamide antimicrobial susceptibility testing. [PDF]
Chan H-H, Wang Y-C, Jou R.
europepmc +1 more source

